SIC
HRMY icon

SJS Investment Consulting’s Harmony Biosciences HRMY Stock Holding History

SJS Investment Consulting’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.76K Buy
213
+171
+407% +$5.39K ﹤0.01% 1191
2026
Q1 		$1.18K Sell
42
-1
-2% -$33 ﹤0.01% 1414
2025
Q4 		$1.61K Buy
43
+39
+975% +$1.28K ﹤0.01% 1179
2025
Q3 		$111 Hold
4
– – ﹤0.01% 1571
2025
Q2 		$127 Sell
4
-2
-33% -$64 ﹤0.01% 1452
2025
Q1 		$200 Hold
6
– – ﹤0.01% 1449
2024
Q4 		$207 Sell
6
-2
-25% -$69 ﹤0.01% 1457
2024
Q3 		$320 Buy
8
+3
+60% +$105 ﹤0.01% 1434
2024
Q2 		$151 Buy
5
+2
+67% +$60 ﹤0.01% 1548
2024
Q1 		$101 Sell
3
-1
-25% -$32 ﹤0.01% 1566
2023
Q4 		$130 Sell
4
-3
-43% -$84 ﹤0.01% 1522
2023
Q3 		$230 Hold
7
– – ﹤0.01% 1432
2023
Q2 		$247 Buy
7
+6
+600% +$207 ﹤0.01% 1364
2023
Q1 		$33 Sell
1
-8
-89% -$364 ﹤0.01% 1545
2022
Q4 		$496 Buy
9
+5
+125% +$275 ﹤0.01% 1220
2022
Q3 		$0 Buy
+4
New +$195 ﹤0.01% 1255
2022
Q1 		$0 Buy
+1
New +$41 ﹤0.01% 988

Other funds holding HRMY

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SJS Investment Consulting's HRMY Position: Q2 2026 in Review

SJS Investment Consulting increased its Harmony Biosciences (HRMY) stake by 407% in Q2 2026, buying an estimated $5.39K and bringing the position to 213 shares worth $7.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

SJS Investment Consulting first reported a position in HRMY in Q1 2022 and has held it in 17 quarters since. 71 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • SJS Investment Consulting held 213 shares of Harmony Biosciences worth $7.76K as of Q2 2026.
  • SJS Investment Consulting bought 171 Harmony Biosciences shares in Q2 2026, an estimated $5.39K.
  • Harmony Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1191 holding.
  • SJS Investment Consulting first reported a position in Harmony Biosciences in Q1 2022 and has held it in 17 quarters since.
  • 71 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.